![Tino Töpper](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Tino Töpper is the founder and CEO of Bottmedical AG, which was founded in 2019.
He is currently the Director of Bottneuro AG.
Tino Töpper active positions
Companies | Position | Start |
---|---|---|
Bottmedical AG
![]() Bottmedical AG Medical SpecialtiesHealth Technology Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019. | Founder | 31/12/2018 |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Bottmedical AG
![]() Bottmedical AG Medical SpecialtiesHealth Technology Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019. | Health Technology |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Tino Töpper